Filing Flows › Hinge Health (HNGE) › Stock forecast & fair value
Hinge Health (HNGE) stock forecast and price target
Hinge Health (HNGE) trades at $115.76. 16 analysts' median price target is $135.00 (+17%), from $90.00 to $151.00.
Hinge Health's latest quarter
Hinge Health, Q3 2026: revenue $235M (+52% year over year), operating margin 21.4%, net earnings $57.4M, operating cash flow $115M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for HNGE stock?
The median of 16 analysts' 12-month targets is $135.00, +17% from $115.76; the range is $90.00 to $151.00. The average rating is buy.
Does Hinge Health usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is HNGE stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.